Caricamento...
Identification of an orally available compound with potent and broad FLT3 inhibition activity
FLT3 internal tandem duplication (FLT3-ITD) is an activating mutation found in 20%-30% of patients with acute myeloid leukemia (AML), which makes FLT3 an attractive target for the treatment of AML. Although FLT3-mutant patients respond to current FLT3 inhibitors, relapse usually happens due to the a...
Salvato in:
| Pubblicato in: | Oncogene |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4809803/ https://ncbi.nlm.nih.gov/pubmed/26411368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2015.362 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|